Juan W. Valle/LinkedIn
Aug 22, 2025, 04:19
Juan W Valle: Funding Opportunity for Early-Career Researchers
Juan W Valle, Chief Medical Officer at Cholangiocarcinoma Foundation, shared a post on LinkedIn:
“Funding Opportunity for Early-Career Researchers:
The Cholangiocarcinoma Foundation (CCF) is accepting Letters of Intent for the 2026 Research Fellowship Program. Since 2015, CCF has awarded $3.83+ million in seed funding to support innovative projects that advance the understanding, treatment, and prevention of cholangiocarcinoma (bile duct cancer).
Applications are welcome from investigators worldwide, including those new to the field.
Funding Highlights:
- Up to $75,000 for one year of grant support
- Basic, translational, or clinical science projects eligible
- Priority areas: early detection, radiomics, drug discovery, immunotherapy, correlative clinical trial studies, and real-world data research
- Travel support for presentation at the 2026 CCF Annual Conference in Salt Lake City, Utah
Key Dates:
- Letters of Intent Open: September 15, 2025
- Deadline: October 10, 2025, 11:59 p.m. ET
- Award Period: June 1, 2026 – May 31, 2027
Together, we can accelerate progress toward a cure and improve the lives of those impacted by cholangiocarcinoma.”
More posts featuring Juan W Valle on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 22, 2025, 04:19
Aug 22, 2025, 02:57
Aug 22, 2025, 02:54
Aug 22, 2025, 02:49
Aug 21, 2025, 23:33
Aug 21, 2025, 20:00